Centiva Capital’s TELA Bio TELA Stock Holding History

Centiva Capital’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-29,000	Closed	-$136K	–	2592
2024 Q2	$136K	Buy	+29,000	New	+$153K	﹤0.01%	1793

Other funds holding TELA

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Centiva Capital's TELA Position: Q3 2024 in Review

Centiva Capital sold out of TELA Bio (TELA) in Q3 2024, closing a stake of 29,000 shares — an estimated $136K sold.

Centiva Capital first reported a position in TELA in Q2 2024 and held it in 1 quarter. The position peaked at $136K in Q2 2024. 49 funds tracked by Wall St. Rank hold TELA as of Q3 2024.

Centiva Capital reported no remaining TELA Bio position as of Q3 2024 after selling out during the quarter.
Centiva Capital sold 29,000 TELA Bio shares in Q3 2024, an estimated $136K.
Centiva Capital first reported a position in TELA Bio in Q2 2024 and held it in 1 quarter.
Centiva Capital's TELA Bio position peaked at $136K in Q2 2024.
49 funds tracked by Wall St. Rank held TELA Bio as of Q3 2024.

Based on Centiva Capital's 13F filing for Q3 2024, filed 14 Nov 2024.